 | Vol. 13.00 – 8 January, 2025 |
| |
|
|
| Scientists generated a panel of recombinant viruses carrying different spike proteins from 27 variants circulating between 2020 and 2024 in the same genomic background. [Nature Microbiology] |
|
|
|
 | PUBLICATIONSListed by the impact factor of the journal |
| |
|
|
| Researchers developed a model of SARS-CoV-2 infection using human-induced pluripotent stem cell-derived endothelial cells, pericytes), and smooth muscle cells to recapitulate the vascular pathology associated with SARS-CoV-2 exposure. [Nature Communications] |
|
|
|
| Investigators demonstrated the value of a second generation of cysteine protease inhibitors that comprised a single agent that acted on both human cathepsin L and SARS-CoV-2 3-chymotrypsin-like (3CL) protease. [Journal of The American Chemical Society] |
|
|
|
| The authors identified a region in the SARS-CoV-2 S2 spike protein with sequence homology to bacterial super-antigens. [Communications Biology] |
|
|
|
| Scientists investigated whether vaccination prior to infection altered the subsequent neurologic post-acute sequelae of SARS-CoV-2 infection. [Brain Communications] |
| MORE IMMUNOLOGY OF INFECTIOUS DISEASE |
|
|
|
| Researchers investigated the incidence of hepatitis D virus infection and its clinical impact in hepatitis B virus-coinfected people with HIV in the era of tenofovir-containing antiretroviral therapy. [Clinical Infectious Diseases] |
|
|
|
| Scientists characterized the stem-specific repertoire of individuals vaccinated with one of three group two influenza subtypes. [Science Translational Medicine] |
|
|
|
| Researchers designed and produced a self-assembling nanoparticle vaccine derived from thermophilic archaeal ferritin to combat epidemic porcine reproductive and respiratory syndrome virus. [ACS Nano] |
|
|
|
| While many studies on booster subunit vaccines have concentrated on recombinant proteins, here scientists developed a novel modular peptide-based subunit vaccine platform that was flexible, cold-chain independent and customizable to diverse circumstances and populations. [Small] |
|
|
|
| Investigators suggested that α4β7hi expression on CD4+ T cells may not predict HIV acquisition and progression in all contexts, which may be due to cohort effects, modes of transmission, viral clade, or other factors. [Journal of Infectious Diseases] |
|
|
|
| Given the impact of nonalcoholic fatty liver disease (NAFLD) on T cell activation and proliferation functions, scientists aimed to explore the heterogeneity of follicular cytotoxic T cells in chronic hepatitis B patients with NAFLD. [Biochimica et Biophysica Acta-Molecular Basis of Disease] |
|
|
|
|
| The authors provide a brief review of the role of viruses in the outset and development of autoimmune rheumatic diseases. [Translational Research] |
|
|
|
|
| ModeX Therapeutics Inc. announces dosing of the first participant in the Phase I study of an Epstein-Barr Virus vaccine candidate being developed in collaboration with Merck, known as MSD outside the United States and Canada. [ModeX Therapeutics, Inc. (Globe Newswire)] |
|
|
|
|
| February 1-4, 2025 San Diego, California, United States |
|
|
|
|
|
| UmeÃ¥ University – UmeÃ¥, Sweden |
|
|
|
| Ulster University – Belfast, Northern Ireland, United Kingdom |
|
|
|
| Medical College of Wisconsin – Milwaukee, Wisconsin, United States |
|
|
|
| Institute of Research for Infectious Diseases of Montpellier – Montpellier, France |
|
|
|
| Cedars Sinai – Los Angeles, California, United States |
|
|
|
|